Pfizer/Boehringer Ingelheim’s Spiriva Linked To Stroke In FDA MedWatch Alert

 
• By Brooke McManus

Pooled analyses of data on COPD treatment show increased risk of stroke in two patients per 1,000, agency says.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet